Literature DB >> 3966985

A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

D E Bullard, D G Thomas, J L Darling, C J Wikstrand, J V Diengdoh, R O Barnard, J G Bodmer, D D Bigner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3966985      PMCID： PMC1977022          DOI： 10.1038/bjc.1985.41

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  24 in total

1.  Autologous glioma transplantation.

Authors:  W H BLOOM; K C CARSTAIRS; M R CROMPTON; W McKISSOCK
Journal:  Lancet       Date:  1960-07-09       Impact factor: 79.321

2.  Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue.

Authors:  D D Bigner; O M Pitts; C J Wikstrand
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

3.  Surface antigens of human glioma cells shared with normal adult and fetal brain.

Authors:  C J Wikstrand; D D Bigner
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

4.  Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction.

Authors:  C J Wikstrand; D D Bigner
Journal:  J Neuroimmunol       Date:  1981-09       Impact factor: 3.478

5.  Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines.

Authors:  D E Bullard; S C Schold; S H Bigner; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1981-07       Impact factor: 3.685

6.  Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test.

Authors:  J R Bean; J L Darling; N R Hoyle; S O Arigbabu; D G Thomas
Journal:  Neurol Res       Date:  1983       Impact factor: 2.448

7.  Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas.

Authors:  M S Mahaley; G Y Gillespie; R P Gillespie; P J Watkins; D D Bigner; C J Wikstrand; J M MacQueen; F Sanfilippo
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

8.  Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study.

Authors:  M S Mahaley; D D Bigner; L F Dudka; P R Wilds; D H Williams; T W Bouldin; J N Whitaker; J M Bynum
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

9.  Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

Authors:  S B Green; D P Byar; M D Walker; D A Pistenmaa; E Alexander; U Batzdorf; W H Brooks; W E Hunt; J Mealey; G L Odom; P Paoletti; J Ransohoff; J T Robertson; R G Selker; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  Cancer Treat Rep       Date:  1983-02

10.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685
View more
  4 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

Review 2.  The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.

Authors:  Amy B Heimberger; John H Sampson
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

3.  Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

Authors:  Denise A Caruso; Lisa M Orme; Alana M Neale; Fiona J Radcliff; Gerlinda M Amor; Wirginia Maixner; Peter Downie; Timothy E Hassall; Mimi L K Tang; David M Ashley
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

Review 4.  Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Authors:  John H Sampson; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Darell D Bigner
Journal:  Semin Immunol       Date:  2008-06-09       Impact factor: 11.130
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.